AMCFX
Price
$43.51
Change
-$1.57 (-3.48%)
Updated
Dec 18 closing price
RGAEX
Price
$73.93
Change
-$9.65 (-11.55%)
Updated
Dec 18 closing price
Ad is loading...

AMCFX vs RGAEX

Header iconAMCFX vs RGAEX Comparison
Open Charts AMCFX vs RGAEXBanner chart's image
American Funds AMCAP F2
Price$43.51
Change-$1.57 (-3.48%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R4
Price$73.93
Change-$9.65 (-11.55%)
VolumeN/A
CapitalizationN/A
AMCFX vs RGAEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMCFX vs. RGAEX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMCFX is a Hold and RGAEX is a Hold.

FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 313B vs. AMCFX (88B). AMCFX pays higher dividends than RGAEX: AMCFX (0.82) vs RGAEX (0.44). AMCFX was incepted earlier than RGAEX: AMCFX (16 years) vs RGAEX (23 years). AMCFX (31.00) and RGAEX (31.00) have comparable annual turnover. AMCFX (250) and RGAEX (250) have matching initial minimum investment requirements. RGAEX (19.06) and AMCFX (18.64) have marching annual gain over last year. RGAEX return over 5 years is better than : 47.36 vs. AMCFX (36.53).
AMCFXRGAEXAMCFX / RGAEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD17.35118.83592%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets88B313B28%
Annual Yield % from dividends0.820.44186%
Returns for 1 year18.6419.0698%
Returns for 3 years3.205.1662%
Returns for 5 years36.5347.3677%
Returns for 10 years62.0174.9183%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COLL30.02-0.88
-2.85%
Collegium Pharmaceutical
IDA108.79-3.33
-2.97%
IDACORP
GIS63.91-2.02
-3.06%
General Mills
AMLX3.94-0.34
-7.94%
Amylyx Pharmaceuticals
WLGS2.03-0.30
-12.88%
Wang & Lee Group